Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms × regorafenib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 14 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Colorectal Neoplasms 58 Carcinoma, Hepatocellular 20 Neoplasm Metastasis 14 Rectal Neoplasms 9 Colonic Neoplasms 8 Gastrointestinal Stromal Tumors 7 Sarcoma 5 Ovarian Neoplasms 5 Glioblastoma 5 Stomach Neoplasms 4 Osteosarcoma 4 Melanoma 4 Pancreatic Neoplasms 3 Liver Neoplasms 3 Leukemia, Myeloid, Acute 3 Esophageal Neoplasms 3 Colorectal Cancer Metastatic 3 Cholangiocarcinoma 3 Carcinoma, Non-Small-Cell Lung 3 Thyroid Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Hematologic Neoplasms 2 Gastrointestinal Neoplasms 2 Gallbladder Neoplasms 2 Fatigue 2

Interventions

Surveys and Questionnaires 98 Exercise 88 Blood Specimen Collection 86 Radiotherapy 60 Gemcitabine 53 Bevacizumab 52 Cisplatin 50 Standard of Care 49 Capecitabine 47 Dexamethasone 44 Cyclophosphamide 44 Carboplatin 44 Docetaxel 41 Paclitaxel 40 Interviews as Topic 40 pembrolizumab 39 Oxaliplatin 38 Methods 35 Irinotecan 35 Fluorouracil 35 Magnetic Resonance Spectroscopy 33 Therapeutics 29 Radiosurgery 28 Nivolumab 27 Drug Therapy 26 Educational Status 25 Leucovorin 22 Everolimus 21 Control Groups 21 Cognitive Behavioral Therapy 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02693535 2026-03-19

TAPUR

American Society of Clinical Oncology

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡